Lucira Health, Inc.

$0.45+0.00%(+$0.00)
TickerSpark Score
63/100
Mixed
100
Valuation
25
Profitability
55
Growth
84
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LHDX research report →

52-Week Range8% of range
Low $0.11
Current $0.45
High $4.35

Companywww.lucirahealth.com

Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services.

CEO
Erik T. Engelson
IPO
2021
Employees
221
HQ
EmeryVille, CA, US

Price Chart

-89.99% · this period
$4.52$2.32$0.11Mar 03Sep 01Mar 03

Valuation

Market Cap
$18.36M
P/E
-0.24
P/S
0.20
P/B
0.08
EV/EBITDA
1.40
Div Yield
0.00%

Profitability

Gross Margin
10.99%
Op Margin
-69.36%
Net Margin
-69.67%
ROE
-102.50%
ROIC
-33.68%

Growth & Income

Revenue
$93.06M · 34492.94%
Net Income
$-64,827,000 · -73.33%
EPS
$-1.86 · -78.85%
Op Income
$-64,540,000
FCF YoY
-126.49%

Performance & Tape

52W High
$4.35
52W Low
$0.11
50D MA
$0.36
200D MA
$1.20
Beta
3.76
Avg Volume
21.45M

Get TickerSpark's AI analysis on LHDX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 3, 23Engelson Erik T.other574,666
Mar 3, 23Engelson Erik T.sell574,666
Mar 3, 23Engelson Erik T.sell60,000
Mar 3, 23Engelson Erik T.other574,666
Mar 3, 23Narido Richard Clavanosell10,674
Mar 3, 23Narido Richard Clavanosell9,675
Mar 3, 23Narido Richard Clavanosell4,742
Mar 6, 23Narido Richard Clavanosell1,910
Mar 7, 23Narido Richard Clavanosell2,382
Mar 3, 23Collins Kevin Waltersell30,102

Our LHDX Coverage

We haven't published any research on LHDX yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate LHDX Report →

Similar Companies